Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder
Academic Article
Overview
MeSH Major
Carcinoma, Squamous Cell
Papilloma
Poly I-C
Urinary Bladder Neoplasms
abstract
A randomized prospective therapeutic trial of poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder is presented. Poly I:C had no beneficial effect on the recurrence rate of superficial bladder tumors.
